Comparison of Nebulized Versus Systemic Corticosteroid for Management of Children Presenting with Acute Exacerbation of Asthma
DOI:
https://doi.org/10.63682/jns.v14i32S.8418Keywords:
Patients, Asthma, Chronic, Respiratory, NebulizedAbstract
Introduction: Asthma is one of the most common chronic respiratory diseases in children, characterized by inflammation, bronchoconstriction, and mucus production in the airways, which leads to recurrent episodes of wheezing, coughing, and shortness of breath.
Objective: The main objective of the study is to find the comparison of nebulized versus systemic corticosteroids for the management of children presenting with acute exacerbation of asthma. Methodology: This randomized controlled trial (RCT) was conducted at Department of Pediatric Medicine, Multan Medical & Dental College from March 2023 to September 2024. A total of 240 pediatric patients, aged 2 to 12 years were included in the study. Data were collected at baseline (upon presentation) and at multiple time points during treatment (12, 24, 48 hours, and discharge). The clinical severity of asthma exacerbations was assessed using the Pediatric Asthma Severity Score (PASS).
Results: Both groups had a comparable mean age (6.4 ± 3.2 years vs. 6.3 ± 3.1 years, p = 0.75) and similar asthma severity as measured by the Pediatric Asthma Severity Score (PASS) (10.2 ± 2.5 vs. 10.1 ± 2.3, p = 0.85). Baseline respiratory rate, oxygen saturation, and gender distribution were also similar between the groups, with no statistically significant differences (p > 0.05 for all comparisons).At 48 hours, 85% of patients in the systemic corticosteroid group showed significant clinical improvement (PASS <4), compared to 68% in the nebulized corticosteroid group (p = 0.01), indicating a greater proportion of patients achieving symptom resolution in the systemic group.
Conclusion: It is concluded that systemic corticosteroids provide more rapid clinical improvement and faster symptom resolution compared to nebulized corticosteroids in children with acute asthma exacerbations.
Downloads
Metrics
References
Marghli, S., Bouhamed, C., Sghaier, A. et al. Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial. BMC Emerg Med 22, 134 (2022). https://doi.org/10.1186/s12873-022-00691-9
Sawanyawisuth, Kanlayanee1,2; Chattakul, Paiboon2,3; Khamsai, Sittichai2,3; Boonsawat, Watchara3; Ladla, Arinrada3; Chotmongkol, Verajit3; Limpawattana, Panita3; Chindaprasirt, Jarin3; Senthong, Vichai3; Phitsanuwong, Chalongchai4; Sawanyawisuth, Kittisak2,3,. Role of Inhaled Corticosteroids for Asthma Exacerbation in Children: An Updated Meta-Analysis. Journal of Emergencies, Trauma, and Shock 13(2):p 161-166, Apr–Jun 2020. | DOI: 10.4103/JETS.JETS_116_19
Chipps BE, Haselkorn T, Rosén K, Mink DR, Trzaskoma BL, Luskin AT. Asthma exacerbations and triggers in children in TENOR: Impact on quality of life. J Allergy Clin Immunol Pract. 2018;6:169–7600.
Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;CD002178.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. [Last accessed on 2018 May 16]. Available from: https://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention.
Arakawa H, Hamasaki Y, Kohno Y, Ebisawa M, Kondo N, Nishima S, et al. Japanese guidelines for childhood asthma 2017. Allergol Int. 2017;66:190–204.
Duse M, Santamaria F, Verga MC, et al. Inter-society consensus for the use of inhaled corticosteroids in infants, children, and adolescents with airway diseases. Ital J Pediatr. 2021;47:97.
Edmonds ML, Milan SJ, Camargo CA Jr, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev. 2012;12:CD002308.
Sawanyawisuth K, Chattakul P, Khamsai S, et al. Role of inhaled corticosteroids for asthma exacerbation in children: An updated meta-analysis. J Emerg Trauma Shock. 2020;13(2):161-166.
Sharma S, Harish R, Dutt N, Digra KK. To evaluate the efficacy of nebulized budesonide compared to oral prednisolone in the management of moderate exacerbation of acute asthma. Int J ContempPediatr. 2017;4:1278–83.
Yanagida N, Tomikawa M, Shukuya A, Iguchi M, Ebisawa M. Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks. World Allergy Organ J. 2015;8:14.
Gillani S, Qazi GA, Ibrahim SK, Bibi S, Farooq AH. Comparison of Nebulized vs Systemic Corticosteroids for Management of Children Presenting with Acute Exacerbation of Asthma. Pakistan Journal of Medical & Health Sciences. 2022 Apr 5;16(02):938-.
Zaffar MU, Ahmad W, Iqbal N. Comparison of Nebulized vs Systemic Corticosteroids for Management of Children Presenting with Acute Exacerbation of Asthma: Nebulized vs Systemic Corticosteroids for acute exacerbation of Asthma. Medical Journal of South Punjab. 2023 Jun 3;4(01):69-75.
Castro‐Rodriguez JA, Pincheira MA, Escobar‐Serna DP, Sossa‐Briceño MP, Rodriguez‐Martinez CE. Adding nebulized corticosteroids to systemic corticosteroids for acute asthma in children: A systematic review with meta‐analysis. Pediatric Pulmonology. 2020 Oct;55(10):2508-17.
Murphy KR, Hong JG, Wandalsen G, Larenas-Linnemann D, El Beleidy A, Zaytseva OV, Pedersen SE. Nebulized inhaled corticosteroids in asthma treatment in children 5 years or younger: a systematic review and global expert analysis. The Journal of Allergy and Clinical Immunology: In Practice. 2020 Jun 1;8(6):1815-27.
Sawanyawisuth K, Chattakul P, Khamsai S, Boonsawat W, Ladla A, Chotmongkol V, Limpawattana P, Chindaprasirt J, Senthong V, Phitsanuwong C, Sawanyawisuth K. Role of inhaled corticosteroids for asthma exacerbation in children: An updated meta-analysis. Journal of Emergencies, Trauma, and Shock. 2020 Apr 1;13(2):161-6.
Kulalert P, Phinyo P, Patumanond J, Smathakanee C, Chuenjit W, Nanthapisal S. Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis. Asthma Research and Practice. 2020 Dec;6:1-0.
Hussain M, Iqbal M, Rayaz S, Bizenjo A. Compare the Effectiveness of Systematic Steroids Verses Nebulizer in Pediatric Patients of Acute Exacerbation of Asthma. Pakistan Journal of Medical & Health Sciences. 2022;16(12):179-.
Hasegawa K, Craig SS, Teach SJ, Camargo Jr CA. Management of asthma exacerbations in the emergency department. The Journal of Allergy and Clinical Immunology: In Practice. 2021 Jul 1;9(7):2599-610.
Schuh S, Sweeney J, Rumantir M, Coates AL, Willan AR, Stephens D, Atenafu EG, Finkelstein Y, Thompson G, Zemek R, Plint AC. Effect of nebulized magnesium vs placebo added to albuterol on hospitalization among children with refractory acute asthma treated in the emergency department: a randomized clinical trial. Jama. 2020 Nov 24;324(20):2038-47.
Pincheira MA, Bacharier LB, Castro-Rodriguez JA. Efficacy of macrolides on acute asthma or wheezing exacerbations in children with recurrent wheezing: a systematic review and meta-analysis. Pediatric Drugs. 2020 Apr;22(2):217-28..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
